Cytokinetics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $249 | $835 | $1,672 | $378 |
Gross Profit | -2,157 | -1,496 | -4,663 | -82,154 |
EBITDA | -127,766 | -123,904 | -121,083 | -115,426 |
EBIT | -130,172 | -126,235 | -127,418 | -117,280 |
Net Income | -143,318 | -135,643 | -136,896 | -129,422 |
Net Change In Cash | 249 | 835 | 1,672 | 378 |
Free Cash Flow | -101,228 | -127,753 | -74,114 | -96,425 |
Cash | 190,517 | 120,351 | 113,399 | 99,692 |
Basic Shares | 109,240 | 101,924 | 99,067 | 96,071 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,530 | $94,588 | $70,428 | $55,828 |
Gross Profit | -4,362 | -146,225 | -89,510 | -41,123 |
EBITDA | -484,313 | -312,860 | -185,982 | -88,614 |
EBIT | -496,205 | -321,259 | -195,619 | -90,445 |
Net Income | -526,244 | -402,552 | -242,370 | -164,135 |
Net Change In Cash | 7,530 | 94,588 | 70,428 | 55,828 |
Cost of Revenue | -45,484 | 29,681 | 46,552 | |
Free Cash Flow | -415,749 | -310,851 | -191,394 | -2,109 |
Cash | 113,399 | 65,582 | 112,666 | 82,985 |
Basic Shares | 96,524 | 89,825 | 76,886 | 64,524 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.31 |
2024-03-31 | -$1.33 |
2023-12-31 | -$1.38 |
2023-09-30 | -$1.35 |
